NCT06674577Phase 2Enrolling by invitation

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Study sponsor: Vera Therapeutics, Inc. · VERA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2031-05-21Estimated

Enrollment · participants750Estimated

Source updated2026-06-22Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-06-22 · 2 fields changed

Planned enrollment increased by 274 participants

− Before

~~476 participants (planned)~~

+ After

750 participants (planned)

Primary completion date changed

− Before

~~31 May 2028~~

+ After

21 May 2031

Check registry source